From $37 billion to nearly $71 billion in a decade: a look at the forces driving biosimilars' next growth phase.
Lauren Gordon
Advertisement
Lauren Gordon is a strategic content lead at Managed Healthcare Executive.
Articles by Lauren Gordon
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Payer Implications and Final Takeaways from the BE BOLD Trial
2
A conversation with Tiffany Phung, Pharm.D., CSP, about how patient outcomes drive specialty pharmacy strategy
3
Endometriosis increases the risk of Type 2 diabetes
4
Journavx helped most patients avoid opioids after surgery, a recent study found
5